Drug companies face tighter rules on funding
Pharmaceutical companies will have to make public the patient organisations that they fund after the first significant reform of the industry's code of conduct in a decade. The code, launched
Pharmaceutical companies will have to make public the patient organisations that they fund after the first significant reform of the industry's code of conduct in a decade. The code, launched